General Information of Drug (ID: DMLN942)

Drug Name
Padeliporfin di-potassium
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0GO0R

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)